About 1 000 reports

Neoantigen Targeted Therapies Market, 2019-2030 ##.

  • Targeted Therapy
  • Therapy
  • United States
  • World
  • Market Size
  • 2.8.3 TARGETED THERAPIES
  • summarizes the treatment algorithm for patients diagnosed

Resistance to one targeted therapy does not therefore necessarily cause resistance to other products.

  • Chemotherapy
  • Targeted Therapy
  • Therapy
  • Market Size
  • Merck & Co., Inc.
  • Launch of Targeted Therapies and Immuno-Oncology Agents to Address Unmet Need in TNBC and Further Drive Market Growth
  • 6.5.2 ANNUAL COST OF THERAPY

Subjects were randomized in a ##:##:## ratio to Weakest performers Strongest performers cycles). receive no additional treatment, one year of Herceptin treatment or two years of Herceptin treatment.

  • Cancer
  • Targeted Therapy
  • AstraZeneca PLC
  • Novartis AG
  • Roche Group
  • THOMSON NC, ET AL. (2012). LEBRIKIZUMAB IN THE PERSONALIZED MANAGEMENT OF ASTHMA. BIOLOGICS: TARGETS AND THERAPY; 6: 329-335

IN IPF TREATMENT, THE MOST COMMON TARGET IS AN ENZYME TARGET.

  • Targeted Therapy
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Biologics, Inc.

Targeted Therapies in Asthma: KOL Insight [2018] ##.

  • Asthma
  • Targeted Therapy
  • North America
  • United Kingdom
  • United States
  • Diagnosed prevalence and treated pool for targeted therapies to increase over the forecast period
  • 7.1.2 INCREASING AWARENESS AND DIAGNOSIS

Subjects were randomized in a ##:##:## ratio to receive no additional treatment, one year of Herceptin treatment or two years of Herceptin treatment.

  • Targeted Therapy
  • Market Size
  • AstraZeneca PLC
  • Genentech, Inc.
  • Novartis AG
  • NEW THERAPIES INCREASE MARKET SEGMENTATION AND DIVERSIFY TREATMENT
  • 6.3.2 ANNUAL COST OF THERAPY

One such limitation is the lack of diversity in targeted therapies.

  • Targeted Therapy
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Novartis AG
  • Roche Group

Targeted Therapies in Asthma: KOL Insight: Update Bulletin [April 2017] This edition presents key opinion leader (KOL) views on recent developments in the targeted asthma treatment market Topics covered include; GlaxoSmithKline’s (GSK) presentation of new data at

  • Monoclonal Antibody
  • Salicylic Acid
  • Targeted Therapy
  • Therapy
  • World
  • BCMA TARGETED THERAPIES: DEVELOPMENT PIPELINE,
  • BCMA TARGETED THERAPIES: DISTRIBUTION BY INDICATION

PATIENTS RECEIVED THE THERAPY AS SPLIT DOSE INFUSIONS OF ##-##X## OR ##-##X## CELLS OVER THREE DAYS (##% ON DAY ##, ##% ON DAY ##, AND ##% ON DAY ##).

  • Targeted Therapy
  • United States
  • Affimed Therapeutics AG
  • Amgen Inc.
  • Celgene Corporation
  • 3.2 HER2-Targeted Therapy
  • 6.7 Japan

Avelumab, a targeted therapy for PD-## receptor, and trastuzumab are the best products in terms of PFS.

  • Monoclonal Antibody
  • Targeted Therapy
  • Market Size
  • AstraZeneca PLC
  • Roche Group

Targeted Therapies in Asthma - 2017 ##.

  • Medical Biotechnology
  • Respiratory Treatment
  • Targeted Therapy
  • Therapy
  • United States
  • TARGETED THERAPIES ARE STRUGGLING TO DELIVER FOR THE TREATMENT OF RECURRENT
  • CLINICAL BENCHMARK OF KEY PIPELINE TARGETED THERAPY DRUGS - OVARIAN CANCER

M. (2011) ' Bevacizumab in the treatment of ovarian cancer. ', Biologics : targets & therapy, ##, pp. ##-##. doi: ##. ##/ BTT.

  • Targeted Therapy
  • United States
  • Forecast
  • AstraZeneca PLC
  • Roche Group
  • 2.6.4 TARGETED THERAPIES
  • Non-hematological Cancer, Global, Key Marketed Products and Approved Indications, 2015

Targeted therapies for breast cancer.

  • Targeted Therapy
  • Market Size
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Pfizer Inc.
  • Targeted Therapy Drug Import
  • Targeted Therapy Drug

Targeted Therapy Drug Import The total Targeted Therapy Drug imports volume in China reached ##. ## million yuan in 2018.

  • Targeted Therapy
  • China
  • ACON Biotech Co., Ltd
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • GLOBAL SALES FORECAST BY COUNTRY FOR PROSTATE CANCER IN 2018 AND 2028
  • GLOBAL (8MM) SALES FORECAST BY DRUG CLASS FOR PROSTATE CANCER IN 2018 AND 2028

PIPELINE AGENTS CONSIST MOSTLY OF IMMUNOTHERAPIES AND TARGETED THERAPIES, THE LATTER OF WHICH CONSIST OF THREE CLASSES OF DRUGS (PARP INHIBITORS, ONE AKT INHIBITOR, AND ONE RADIOLIGAND).

  • Targeted Therapy
  • East Asia
  • United States
  • Forecast
  • Pfizer Inc.
  • Aromatase Inhibitors (Targeted Therapy Drug)
  • Targeted Therapy Drug Major Producer and Their

The targeted therapy drug has strong specificity and better curative effort.

  • Targeted Therapy
  • China
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • Beijing Novartis Pharma Ltd
  • PROVIDES A SUMMARY OF THE SWOT ANALYSIS OF OFATUMUMAB.
  • 9.4.1 OFATUMUMAB

GNBAC-##: GLOBALDATA EXPECTS GNBAC-## TO BE PRICED IN LINE WITH OCREVUS BASED ON ITS TARGET INDICATION AND THERAPY CLASS.

  • Targeted Therapy
  • United States
  • Forecast
  • Biogen Idec Inc.
  • Novartis AG
  • Targeted Therapy Drug Sales Volume (million Yuan)
  • Targeted Therapy Drug Sales Volume by Drugs Classification in 2018(percent)

The next stage of targeted therapies will focus on finding which patients will respond to which targeted therapies.

  • Targeted Therapy
  • China
  • Demand
  • AstraZeneca China Inc.
  • Bayer Schering Pharmaceutical Co., Ltd
  • 2.7.3.2 Targeted Therapy
  • 7.2.2 DEALS BY STAGE OF DEVELOPMENT AND VALUE

Targeted therapies, cancer immunotherapies and therapies targeting signal transduction therapies feature prominently, reflecting the success of such therapies in the current market.

  • Targeted Therapy
  • Market Size
  • Celgene Corporation
  • Novartis AG
  • Roche Group

In addition, factors such as rising focus on the development of targeted therapies and advancements in antigen specific T-cell therapy for cancer are providing traction for global Tumor-specific market growth over the forecast period (2018- 2023).

  • Medical Biotechnology
  • Monoclonal Antibody
  • Targeted Therapy
  • World
  • Forecast
  • 8.3 RESISTANCE TO HER2-TARGETED THERAPIES
  • IXEMPRA SWOT ANALYSIS, 2017

Pfizer' s current portfolio for breast cancer consists of one marketed hormone therapy, Aromasin, and one targeted therapy, Ibrance, which is being investigated in Phase III for HER##-positive disease.

  • Targeted Therapy
  • Company
  • Novartis AG
  • Pfizer Inc.
  • Roche Group
  • Launch of Novel Targeted Therapies and Biosimilars to Drive Market Growth
  • B) Aggregate deal value by molecule type

Psoriasis: Targets and Therapy; ##: ##-##.

  • Targeted Therapy
  • Market Size
  • AbbVie Inc.
  • Janssen Biotech, Inc.
  • Novartis AG

Targeted Therapies In Asthma: Update Bulletin [April 2016] This edition presents key opinion leader (KOL) views on recent developments in the asthma market, including the clinical role of Nucala (mepolizumab; GSK) the prospects for Teva’s recently approved Cinqair (reslizumab) and

  • Medical Biotechnology
  • Monoclonal Antibody
  • Oncology
  • Targeted Therapy
  • Therapy
  • MOST PRESCRIBED TARGETED THERAPIES FOR MCRC, BY SEGMENT IN THE 8MM, 2016
  • STIVARGA SWOT ANALYSIS, 2016

MOLECULAR THERAPY; ##(##): ##-##.

  • Targeted Therapy
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • 2.8.3 TARGETED THERAPIES
  • 3.3 Epidermal Growth Factor Receptor Targeted Therapies

Oncobiology and Targets; ##(##): ## Mirghani H, et al. (2015).

  • Targeted Therapy
  • Market Size
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • TARGETED THERAPY
  • Market drivers

Source: Technavio TARGETED THERAPY Targeted therapy focuses on specific abnormalities within cancer cells that enable to survive.

  • Targeted Therapy
  • Amgen Inc.
  • Celgene Corporation
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Entry of Novel Targeted Therapies and Triple-Combination Therapies to Expand Treatment Options
  • Pipeline Analysis

The pipeline is strong, with targeted therapies expected to be launched during the forecast period, including IL-##-targeting therapies, which are expected to witness high uptake.

  • Targeted Therapy
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline plc
  • Novartis AG
  • Treatment Response and Failure in CML Patients
  • I. Global CML Market

Targeted Therapy Targeted therapy targets the onco-genes, proteins, or the tissue environment that contributes to cancer development and survival.

  • Targeted Therapy
  • Incyte Corporation
  • Merck & Co., Inc.
  • Novartis AG
  • Roche Group
  • TARGETED THERAPIES
  • CDK Inhibitors

TREATMENT DAYS: GAZYVA IS ADMINISTERED AT A DOSE OF ##, ##MG IV ON DAYS ##/ ##, ##, AND ## OF CYCLE ##, AND ON DAY ## OF CYCLES ##-##.

  • Targeted Therapy
  • AbbVie Inc.
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • Roche Group
  • Targeted therapy-IR
  • Targeted therapy-IR

US-based KOL Europe-based KOL Europe-based KOL Current use of tocilizumab in RA (##/ ##) Targeted therapy-IR Patients in which tocilizumab is currently used KOL Insight: Most KOLs position tocilizumab after anti-TNFs, partly due to payer pressure, with first-line use pos

  • Medical Biotechnology
  • Monoclonal Antibody
  • Targeted Therapy
  • European Union
  • United States